๐ต๏ธ Kairos Pharma, Ltd. ($KAPA)
SEC insider & ownership activity, last 12 months ยท CIK 1962011 ยท every row links its SEC filing
Insiders were quiet over the last 12 months โ no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 16, 2026 | filing โ |
| Other events (8.01) | Jul 16, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing โ |
| Other events (8.01) | Jul 15, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 15, 2026 | filing โ |
| Shareholder vote (5.07) | Jun 29, 2026 | filing โ |
| Other events (8.01) | Jun 4, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing โ |
| Other events (8.01) | May 18, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing โ |
| Material agreement (1.01) | Mar 2, 2026 | filing โ |
| Other events (8.01) | Mar 2, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing โ |
| Other events (8.01) | Feb 26, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing โ |
| Officer/director changes (5.02) | Oct 8, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 8, 2025 | filing โ |
| Material agreement (1.01) | Oct 1, 2025 | filing โ |
| Other events (8.01) | Oct 1, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 1, 2025 | filing โ |
| Other events (8.01) | Sep 18, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 18, 2025 | filing โ |
| Other events (8.01) | Sep 11, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 11, 2025 | filing โ |
| Other events (8.01) | Sep 3, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 3, 2025 | filing โ |